NCT00002037View on ClinicalTrials.gov

Evaluation of the Therapeutic Benefit of r-metHuIFN- Gamma in AIDS Patients With Disseminated Mycobacterium Avium-Intracellulare (MAI) Infection: A Multi-Centered Pilot Study

NACompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

Not specified

Conditions
Mycobacterium Avium-Intracellulare InfectionHIV Infections
Interventions
DRUG

Trifluridine

Trial Locations (1)

10021

New York Hosp - Cornell Med Ctr, New York

Sponsors

Lead Sponsor

Amgen
All Listed Sponsors
lead

Amgen

INDUSTRY

NCT00002037 - Evaluation of the Therapeutic Benefit of r-metHuIFN- Gamma in AIDS Patients With Disseminated Mycobacterium Avium-Intracellulare (MAI) Infection: A Multi-Centered Pilot Study | Biotech Hunter | Biotech Hunter